Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,760,624
-
Share change
-
+6,675,418
-
Total reported value
-
$209,200,317
-
Put/Call ratio
-
83%
-
Price per share
-
$5.85
-
Number of holders
-
84
-
Value change
-
+$39,154,829
-
Number of buys
-
56
-
Number of sells
-
27
Institutional Holders of AUGMEDIX INC - COM (AUGX) as of Q4 2023
As of 31 Dec 2023,
AUGMEDIX INC - COM (AUGX) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,760,624 shares.
The largest 10 holders included
Redmile Group, LLC, Samjo Management, LLC, Divisadero Street Capital Management, LP, PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, Parkman Healthcare Partners LLC, Russell Investments Group, Ltd., G2 Investment Partners Management LLC, ARDSLEY ADVISORY PARTNERS LP, and AMERICAN FINANCIAL GROUP INC.
This page lists
84
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.